Intellectual Property Watch is an independent news source covering international IP law and policy

Explore its archives, which span from 2005-2019, with the menu above or the link below.
Or, explore our updates on WIPO Committees, beginning in 2006.

Counterfeit Medicines In WTO Dispute Process, Heating Up At WHO

ByKaitlin Mara May 12, 2010

The international policy debate over counterfeit medicines and legitimate generics escalated today. Brazil and India took the first step in the World Trade Organization dispute settlement process for treatment of generics medicines falsely labelled counterfeit in Europe, and non-governmental organisations…

WHA Agrees On Drafting Of Roadmap For Access To Medicines And Vaccines; US Blasts Compulsory Licences

ByCatherine Saez May 24, 2018
WHA Agrees On Drafting Of Roadmap For Access To Medicines And Vaccines; US Blasts Compulsory Licences

The World Health Assembly yesterday agreed on a roadmap to be designed by the World Health Organization in consultation with member states to facilitate access to medicines and vaccines, including actions and activities for the period 2019-2023. If everyone agrees…

Intellectual Property Regime Stifles Science and Innovation, Nobel Laureates Say

ByDugie Standeford Jul 7, 2008

By Dugie Standeford for Intellectual Property Watch MANCHESTER, UK – The basic framework of the intellectual property (IP) regime aims to “close down access to knowledge” rather than allowing its dissemination, Professor Joseph Stiglitz said at a 5 July lecture…

Swiss Group Suggests Switzerland Use Compulsory Licences To Curb Cancer Drug Prices

ByCatherine Saez May 24, 2018
Swiss Group Suggests Switzerland Use Compulsory Licences To Curb Cancer Drug Prices

During a side event held alongside this week’s World Health Assembly, public health advocates proposed that Switzerland use compulsory licensing as a way to decrease what they said are exorbitant drug prices.